Celldex Therapeutics
CLDX
#4701
Rank
โ‚น175.80 B
Marketcap
โ‚น2,646
Share price
-0.51%
Change (1 day)
19.88%
Change (1 year)

Celldex Therapeutics (CLDX) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น52.39 Billion

According to Celldex Therapeutics's latest financial reports the company has โ‚น52.39 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Celldex Therapeutics - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น62.21 B76.44%
2023-12-31โ‚น35.26 B39.74%
2022-12-31โ‚น25.23 B-16.95%
2021-12-31โ‚น30.38 B113.71%
2020-12-31โ‚น14.21 B209.7%
2019-12-31โ‚น4.59 B-30.16%
2018-12-31โ‚น6.57 B-26.15%
2017-12-31โ‚น8.90 B-30.97%
2016-12-31โ‚น12.89 B-33.06%
2015-12-31โ‚น19.26 B51.19%
2014-12-31โ‚น12.74 B-31.93%
2013-12-31โ‚น18.71 B307.17%
2012-12-31โ‚น4.59 B63.01%
2011-12-31โ‚น2.82 B3.01%
2010-12-31โ‚น2.73 B-28.44%
2009-12-31โ‚น3.82 B79.85%
2008-12-31โ‚น2.12 B1004.04%
2007-12-31โ‚น0.19 B-89.37%
2006-12-31โ‚น1.81 B71.93%
2005-12-31โ‚น1.05 B-23.34%
2004-12-31โ‚น1.37 B49.09%
2003-12-31โ‚น0.92 B-23.31%
2002-12-31โ‚น1.20 B-41.6%
2001-12-31โ‚น2.05 B-12.09%
2000-12-31โ‚น2.34 B295.54%
1999-12-31โ‚น0.59 B56.45%
1998-12-31โ‚น0.37 B50.46%
1997-12-31โ‚น0.25 B-44.47%
1996-12-31โ‚น0.45 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Seagen
SGEN
โ‚น111.12 B 112.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น0.31 B-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น22.05 B-57.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น848.50 B 1,519.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.346 T 2,469.17%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น399.26 B 662.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
โ‚น0.25 B-99.52%๐Ÿ‡บ๐Ÿ‡ธ USA